Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threat
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation, By Mode of Delivery
6.1 Oral Delivery Devices
6.2 Pulmonary Drug Delivery Devices
6.3 Transdermal Drug Delivery Systems
6.4 Injectable Drug Delivery system
Chapter 7 Market Segmentation, By Mode of Action
7.1 Hydrodynamic pressure controlled system
7.2 Slow dissolving salts and complexes
7.3 Ion-exchange resin-drug complexes
7.4 PH-Independent formulations
7.5 Osmotic pressure controlled systems
7.6 Dissolution and diffusion controlled release systems
Chapter 8 Market Segmentation, By Mode of Administration
8.1 Inhalation drug delivery system by nebuliser
8.2 Inhalation drug delivery system by dry powder inhalers
8.3 Inhalation drug delivery system by metered dose inhalers
8.4 Iontophoresis
8.5 Use of microscopic projection
8.6 Application by ultrasound
8.7 Electroporation
8.8 Intraperitoneal injection
8.9 Intradermal injection
8.10 Intravenous injection
8.11 Intramuscular injection
8.12 Subcutaneous injection
Chapter 9 Market Segmentation, By Geography
8.1 Introduction
8.2 USA
8.3 Canada
8.4 Mexico
8.5 Others
Chapter 10 Competitive Landscape
10.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
10.2 Market Share Analysis
10.3 Strategies Adopted By Top Companies
Chapter 11 Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
11.1. Mylan Laboratories Inc.
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Strategic Initiative
11.2. Oncolytics Biotech
11.3. Johnson & Johnson
11.4. Boston Scientific
11.5. Amgen Inc.
11.6. Abbott Laboratories
11.7. 3M Company
11.8. Kala Pharmaceuticals
11.9. Mersana Therapeutics
11.10. Valeritas
11.11. MedVantx
11.12. Carbylan Therapeutics
11.13. Orbis Biosciences
11.14. Zosano Pharma
11.15. Delpor
Chapter 12 Market Estimates and Forecast
12.1 Market Estimates and Forecast 2018-2024(USD Million)
12.1.1 Market Estimation and Forecast by Mode of Delivery 2018-2024 (USD Million)
12.1.2 Market Estimation and Forecast by Mode of Action 2018-2024 (USD Million)
12.1.3 Market Estimation and Forecast by Mode of Administration 2018-2024 (USD Million)
12.1.4 Market Estimates and Forecast by Geography 2018-2024 (USD Million)
Chapter 13 Market Insights
13.1 Insights of Industry Experts
13.2 Analyst Opinion (Market Understanding)
13.3 Investment Opportunities
Chapter 14 Appendix
14.1 List of Tables
14.2 List of Figures
